오클라호마의 심혈관 질환 임상 시험
심혈관 질환 관련 연구 13개가 오클라호마 내 여러 지역에서 참여자를 모집하고 있습니다.
오클라호마의 도시
공식 연구 텍스트(영어)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07064473INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- Saint Francis Hospital - Tulsa, Tulsa
피험자 모집 중
18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06965504A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
피험자 모집 중
18세 ~ 85세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07214376Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06526195Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System
- Oklahoma Heart Institute, Tulsa
피험자 모집 중
18세 ~ 90세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07687485Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Integris Baptist Medical Center, Oklahoma City
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT03242642Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06909565A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Oklahoma City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Alliance for Multispecialty Research, Norman
피험자 모집 중3상
50세 ~ 105세 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT07136012The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT03142152MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
피험자 모집 중
18세 ~ 80세 · 모든 성별 · 2025. 9. 11. 업데이트됨 · NCT06271590MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
피험자 모집 중
18세 ~ 110세 · 모든 성별 · 2025. 2. 25. 업데이트됨 · NCT05908331ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.